Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 364

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study

Open access
Grulich, Andrew E, Guy, Rebecca, Amin, Janaki, Jin, Fengyi, Selvey, Christine, Holden, Jo, Schmidt, Heather-Marie A, Zablotska, Iryna, Price, Karen, Whittaker, Bill, Chant, Kerry, Cooper, Craig, McGill, Scott, Telfer, Barbara, Yeung, Barbara, Levitt, Gesalit, Ogilvie, Erin E, Dharan, Nila J, Hammoud, Mohamed A, Vaccher, Stefanie, Watchirs-Smith, Lucy, McNulty, Anna, Smith, David J, Allen, Debra M, Baker, David, Bloch, Mark, Bopage, Rohan I, Brown, Katherine, Carr, Andrew, Carmody, Christopher J, Collins, Kym L, Finlayson, Robert, Foster, Rosalind, Jackson, Eva Y, Lewis, David A, Lusk, Josephine, O'Connor, Catherine C, Ryder, Nathan, Vlahakis, Emanuel, Read, Phillip, Cooper, David A, Smith, Don, Ooi, Catriona, Martin, Sarah, Soo, Tuck Meng, Templeton, David, Townson, David, Forssman, Brad, Doong, Nick, Han Thai, Gai, Anderson, Ben, MacLeod, Hugh, Parkhill, Nicolas·2018·The Lancet HIV

Abstract

BACKGROUND HIV pre-exposure prophylaxis (PrEP) is highly effective in men who have sex with men (MSM) at the individual level, but data on population-level impact are lacking. We examined whether rapid, targeted, and high-coverage roll-out of PrEP in an MSM epidemic would reduce HIV incidence in the cohort prescribed PrEP and state-wide in Australia's most populous state, New South Wales. METHODS The Expanded PrEP Implementation in Communities-New South Wales (EPIC-NSW) study is an implementation cohort study of daily co-formulated tenofovir disoproxil fumarate and emtricitabine as HIV PrEP. We recruited high-risk gay men in a New South Wales-wide network of 21 clinics. We report protocol-specified co-primary outcomes at 12 months after recruitment of the first 3700 participants: within-cohort HIV incidence; and change in population HIV diagnoses in New South Wales between the 12-month periods before and after PrEP roll-out. The study is registered with ClinicalTrials.gov, number NCT02870790. FINDINGS We recruited 3700 participants in the 8 months between March 1, 2016, and Oct 31, 2016. 3676 (99%) were men, 3534 (96%) identified as gay, and 149 (4%) as bisexual. Median age was 36 years (IQR 30-45 years). Overall, 3069 (83%) participants attended a visit at 12 months or later. Over 4100 person-years, two men became infected with HIV (incidence 0·048 per 100 person-years, 95% CI 0·012-0·195). Both had been non-adherent to PrEP. HIV diagnoses in MSM in New South Wales declined from 295 in the 12 months before PrEP roll-out to 221 in the 12 months after (relative risk reduction [RRR] 25·1%, 95% CI 10·5-37·4). There was a decline both in recent HIV infections (from 149 to 102, RRR 31·5%, 95% CI 11·3 to 47·3) and in other HIV diagnoses (from 146 to 119, RRR 18·5%, 95% CI -4·5 to 36·6). INTERPRETATION PrEP implementation was associated with a rapid decline in HIV diagnoses in the state of New South Wales, which was greatest for recent infections. As part of a combination prevention approach, rapid, targeted, high-coverage PrEP implementation is effective to reduce new HIV infections at the population level. FUNDING New South Wales Ministry of Health, Gilead Sciences.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2352-3018(18)30215-7

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 21 references

Cited by

See all 364

Metadata

Authors
Grulich, A. E., Guy, R., Amin, J., Jin, F., Selvey, C., Holden, J., Schmidt, H.-M. A., Zablotska, I., Price, K., Whittaker, B., Chant, K., Cooper, C., McGill, S., Telfer, B., Yeung, B., Levitt, G., Ogilvie, E. E., Dharan, N. J., Hammoud, M. A., Vaccher, S., Watchirs-Smith, L., McNulty, A., Smith, D. J., Allen, D. M., Baker, D., Bloch, M., Bopage, R. I., Brown, K., Carr, A., Carmody, C. J., Collins, K. L., Finlayson, R., Foster, R., Jackson, E. Y., Lewis, D. A., Lusk, J., O'Connor, C. C., Ryder, N., Vlahakis, E., Read, P., Cooper, D. A., Smith, D., Ooi, C., Martin, S., Soo, T. M., Templeton, D., Townson, D., Forssman, B., Doong, N., Han Thai, G., Anderson, B., MacLeod, H., & Parkhill, N.
Venue
The Lancet HIV
Publisher
Elsevier BV
Published
2018-11
Volume
5
Issue
11
Pages
e629-e637
ISSN
2352-3018 (ISSN-L)
OpenAlex
W2896818093
Cited by
364
References
21
FWCI
30.60
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study. https://app.cochat.ai/papers/10.1016/s2352-3018(18)30215-7
The paper
Grulich, A. E., Guy, R., Amin, J., Jin, F., Selvey, C., Holden, J., Schmidt, H.-M. A., Zablotska, I., Price, K., Whittaker, B., Chant, K., Cooper, C., McGill, S., Telfer, B., Yeung, B., Levitt, G., Ogilvie, E. E., Dharan, N. J., Hammoud, M. A., . . . Parkhill, N. (2018). Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study. The Lancet HIV. https://doi.org/10.1016/s2352-3018(18)30215-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.